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ABST RACT
Gastroesophageal reflux disease (GERD) is known as the most prevalent
gastrointestinal disorder in the United States, leading to substantial morbidity,
although associated mortality is rare. Based on the appearance of esophageal
mucosa on upper endoscopy, GERD is divided into erosive esophagitis (ERD)
and nonerosive reflux disease (NERD). Heartburn and acid regurgitation are
the typical symptoms of the disease, although some patients may present
atypical manifestations such as epigastric pain, nausea, asthma, chronic cough,
pharyngitis, laryngitis, sleep disturbances, otitis, and sinusitis. Other signs,
such as oral mucosal lesions may result from GERD by direct acid or acidic
vapor contact in the oral cavity. Oral manifestations such as tooth erosion,
periodontitis, gingivitis, palatal erythema, ulceration, glossitis, oral acid
burning sensation, halitosis, xerostomia have recently been reported in GERD
patients. A considerable percentage of the patients are affected by oral
manifestations before the onset of gastrointestinal symptoms, although in most
cases the gastrointestinal signs and symptoms dominate the clinical picture.
The injured oral mucosa negatively impacts the quality of life, especially
functional limitation, physical inability and psychological disabilities, thus
leading to social isolation. There is plenty of non-standardized information on
the oral mucosal changes in GERD. In this context, we aimed at synthesizing
and analyzing the current available evidence on non-dental oral cavity lesions
and complaints that are present in patients diagnosed with GERD.

Introduction
Gastroesophageal reflux disease (GERD) is a condition
that develops when the reflux of the stomach contents
causes troublesome symptoms and/or complications [1].
GERD is known as the most prevalent gastrointestinal
disorder in the United States, leading to substantial
morbidity, although associated mortality is rare [2]. Based
on the appearance of the esophageal mucosa on upper
endoscopy, GERD is divided into erosive esophagitis
(ERD) and nonerosive reflux disease (NERD) [3].
Heartburn and acid regurgitation are the typical symptoms
of the disease, although some patients may present atypical
manifestations such as epigastric pain, nausea, asthma,
chronic cough, pharyngitis, laryngitis, sleep disturbances,
otitis, sinusitis [4]. Other signs, such as oral mucosal
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lesions may result from GERD by direct acid or acidic
vapor contact in the oral cavity. The oral manifestations,
such as tooth erosion, periodontitis, gingivitis, palatal
erythema, ulceration, glossitis, oral acid burning sensation,
halitosis, xerostomia have recently been reported in GERD
patients [5]. A considerable percentage of the patients are
affected by oral manifestations before the onset of the
gastrointestinal symptoms, although in most cases the
gastrointestinal signs and symptoms dominate the clinical
picture [6]. The injured oral mucosa negatively impacts the
quality of life, especially functional limitation, physical
inability and psychological disabilities, thus leading to
social isolation [7]. There is plenty of non-standardized
information on oral mucosal changes in GERD [8]. In this
context, we aimed at synthesizing and analyzing the
current available evidence on non-dental oral cavity lesions
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and complaints that are present in patients diagnosed with
GERD.

Discussions
This review with meta-analysis is grounded in a
structured protocol, developed using the Preferred
Reporting Items for Systematic Review and Meta-Analysis
Protocols (PRISMA) [9,10].
Research strategy. PubMed, Web of Science, Science
Direct, Embase and Cochrane Library were searched by
two independent researchers using a pre-piloted screening

and selection tool in order to identify the eligible studies
published between January 2000 and June 2020. The
search was based upon Medical Subjective Heading
(Mesh) terms of “Mouth Diseases” and "Gastroesophageal
Reflux" (Table 1).
All articles relevant to the topic of this paper were
retrieved and their bibliographies were hand searched for
further references.
The screening and selection process consisted of two
stages: 1) screening of title and abstracts and 2) screening
and selection of full text papers (Figure 1).

Table 1. Search strategy
PubMed
("Mouth Diseases"[Mesh]) AND "Gastroesophageal Reflux"[Mesh]
Web of Science
("Behcet Syndrome" OR “Bell Palsy" OR “Burning Mouth Syndrome” OR “Candidiasis, Oral” OR “Dry Socket” OR
“Facial Hemiatrophy” OR “Facial Nerve Diseases” OR “Bell Palsy” OR “Facial Hemiatrophy” OR “Facial Nerve
Injuries” OR “Facial Neuralgia” OR “Herpes Zoster Oticus” OR “Melkersson-Rosenthal Syndrome” OR “Mobius
Syndrome” OR “Facial Paralysis” OR “Focal Epithelial Hyperplasia” OR “Granulomatosis, Orofacial” OR
“Hemifacial Spasm” OR “Leukoedema, Oral” OR “Lichen Planus, Oral” OR “Lip Diseases” OR “Cheilitis” OR “Cleft
Lip” OR “Herpes Labialis” OR “Lip Neoplasms” OR “Ludwig's Angina” OR “Melkersson-Rosenthal Syndrome” OR
“Mouth Abnormalities” OR “Cleft Lip” OR “Cleft Palate” OR “Fibromatosis, Gingival” OR “Macrostomia” OR
“Microstomia” OR “Velopharyngeal Insufficiency” OR “Mouth Neoplasms” OR “Gingival Neoplasms” OR
“Leukoplakia” OR “Lip Neoplasms” OR “Palatal Neoplasms” OR “Salivary Gland Neoplasms” OR “Tongue
Neoplasms” OR “Edentulous” OR “Mucositis” OR “Noma” OR “Oral Fistula” OR “Dental Fistula” OR “Oroantral
Fistula” OR “Salivary Gland Fistula” OR “Oral Hemorrhage” OR “Gingival Hemorrhage” OR “Oral Manifestations”
OR “Oral Submucous Fibrosis” OR “Oral Ulcer” OR “Periodontal Diseases” OR “Furcation Defects” OR “Gingival
Diseases” OR “Peri-Implantitis” OR “Periapical Diseases” OR “Periodontal Atrophy” OR “Periodontal Cyst” OR
“Periodontitis” OR “Tooth Loss” OR “Tooth Migration” OR “Tooth Mobility” OR “Ranula” OR “Salivary Gland
Diseases” OR “Mikulicz' Disease” OR “Parotid Diseases” OR “Salivary Calculi” OR “Salivary Gland Fistula” OR
“Salivary Gland Neoplasms” OR “Sialadenitis” OR “Sialometaplasia” OR “Sialorrhea” OR “Submandibular Gland
Diseases” OR “Xerostomia” OR “Stomatitis” OR “Stevens-Johnson Syndrome” OR “Vesicular Stomatitis” OR
“Tongue Diseases” OR “Glossalgia” OR “Glossitis” OR “Glossoptosis” OR “Macroglossia” OR “Tongue
Neoplasms” OR “Oral Tuberculosis”) AND (“Gastric Acid Reflux” OR “Acid Reflux Gastric” OR “Reflux Gastric
Acid” OR “Gastric Acid Reflux Disease” OR “Gastro-Esophageal Reflux” OR “Gastro Esophageal Reflux” OR
“Reflux Gastro-Esophageal” OR “Gastroesophageal Reflux Disease” OR “GERD” OR “Reflux Gastroesophageal”
OR “Esophageal Reflux” OR “Gastro- oesophageal Reflux” OR “Gastro oesophageal Reflux” OR “Reflux Gastrooesophageal”)
Science Direct
("gastroesophageal reflux" OR "Gastric Acid Reflux") AND ("oral disease" OR "oral lesion" OR "mouth disease"
OR "mouth lesion")
Embase
('gastroesophageal reflux' OR 'gastric acid reflux') AND ('mouth disease' OR 'mouth lesion’ OR 'oral disease' OR
'oral lesion')
Cochrane Library
('gastroesophageal reflux' OR 'gastric acid reflux') AND ('mouth disease' OR 'mouth lesion’ OR 'oral disease' OR
'oral lesion')
61
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Inclusion and exclusion criteria. The selected studies
for the systematic review fulfilled the following criteria: (a)
cross-sectional and case-control studies, (b) publications in
English, (c) regardless of the publication status (published,
in press, or in progress) (d) conducted on adults clinically
diagnosed with GERD who underwent at least one
additional evaluation for the confirmation of the diagnosis
- upper gastrointestinal endoscopy, esophageal manometry
or esophageal pH monitoring, (e) reporting results on the
presence of non-dental oral cavity lesions or oral
complaints. We excluded experimental studies, case
presentations, case series, systematic reviews, articles
published in other languages than English, or conducted
among children populations.
The documents were handled using the Mendeley
reference manager software. The selection process was
conducted by two independent reviewers, while
disagreements were settled by means of group discussions
until a consensus was reached.
62

Data extraction. The data were extracted by two
independent researchers using a pre-defined extraction
form. Any disagreement between these two authors was
resolved by means of group discussions. For each study,
the following data were extracted: title, first author, year of
publication, country, type of study, GERD diagnostic
method, number of patients for the reported groups,
gender, mean age, the use of PPI (proton pump inhibitor)
therapy, reported exclusion criteria, data on the oral cavity
assessment, type of lesion, type of complaint, odds ratio
with confidence interval, mean plus standard deviation, p
value.
Meta-analysis. For the studies reporting homogenous
data, the relationship between the presence of GERD and a
specific non-dental oral cavity lesion or a specific oral
complaint was examined based on the odds ratio (OR) and
its 95% confidence interval (CI). For studies measuring a
specific score, the mean and standard deviation (SD) were
used to calculate the standard mean difference (SMD) and
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the 95% CI. Effect sizes were interpreted using Cohen’s
Standards for Interpreting Effect Sizes [11]. Assuming the
differences in the methodology of the studies included in
the meta-analysis, a random effect model was used. All
calculations were conducted in the Comprehensive MetaAnalysis® software (v3).
The heterogeneity of the studies was analyzed using the
I2 statistic, where a I2 ≥ 75% indicated important
heterogeneity, with p < 0.05 defined statistical
significance. Tau2 (τ2) was calculated using the restricted
maximal likelihood method. Results showing important
heterogeneity are reported in this article, but they cannot
be used to generalize conclusions. The publication bias was
analyzed using Egger’s regression, with p < 0.05 defining
statistical significance and funnel plots for graphical
description. In the event of publication bias, the Rosenthal
method was used to calculate the fail-safe N statistic.
Some of the studies included in the meta-analysis
compared GERD patients to different control subgroups,
younger and older controls [12,13]. This problem was
solved by combining the two control subgroups to form a
single one, according to Cochrane Guidelines [14]. Some
studies calculated scores to define oral lesions/symptoms.
The PMA Index (papillary marginal attachment index: P
was defined as “any degree of inflammation of the
interdental papilla mesial to the tooth”; M was defined as
“any degree of inflammation of the marginal gingiva on the
facial aspect”; A was defined as “any disturbance of
attachment as indicated by any degree of recession of the
marginal gingiva from normal contour”) was used to define
gingivitis in two studies [12,13] and Saxon test (simple,
reproducible, and low-cost test for xerostomia, which
involves chewing on a folded sterile sponge for 2 minutes;
saliva production is quantitated by weighing the sponge

before and after chewing and it was used to define
xerostomia; normal control subjects produced greater than
or equal to 2.75 gm of saliva in 2 minutes) in two studies
[12,13]. Two of the studies [12,13] that quantify
xerostomia measured the quantity of saliva in grams
secreted in 2 minutes, while the other two in
milliliters/minute [15,16]. The results were analyzed
together, assuming that the difference in protocols were
negligible.
Study inclusion. The systematic search provided a total
of 615 citations (Figure 1). Three additional citations were
identified by means of manually searching the relevant
references for the field published papers. After eliminating
the duplicates, 599 studies remained. Out of these, 509
were discarded because they did not meet the inclusion
criteria. The full text of the remaining 50 citations was
examined in detail. Forty full-text published studies did not
meet the inclusion criteria and were excluded from the
analysis. The reasons for exclusion were: published in
other languages than English (n=8), no clinical
examination of the oral cavity (n=14), GERD diagnosis
based only on clinical manifestations (n=15), abstracts
only (n=2), children patients (n=1). Experimental studies,
case presentations, and case series were also excluded.
Ten studies were included for the narrative synthesis
[12,13,15–22]. Two studies did not include a control group
(healthy subjects) and were, therefore, excluded from the
quantitative analysis [17,19]. Only one study reported
periodontitis in both patients and healthy controls and was
impossible to be analyzed quantitatively [18]. One study
reported different measures of gingivitis and was
consequently excluded from the meta-analysis [22].
Accordingly, 6 studies were deemed eligible for inclusion
in the meta-analysis (Table 2).

Table 2. Studies included for the narrative synthesis
No.

1.

2.

First Country GERD M (%)
author,
diagnosis
year

Warsi I Pakistan
2019

Watanabe Japan
M

2017

F (%)

Age Controls GERD ERD NERD Chronic/ Mild Reported Reported Citation
(mean (heathy
(%) (%) (%) severe GERD lesion complaint
GERD without
± SD ) subjects)
DE
with DE
(%)

UGE

109
78
41-60
(58.3%) (41.7 %) (80%)

UGE,
GF

57
48
66.4 ±
50
105
(54.3%) (45.7%) 13.0 (32.3%) (67.7%)
(GERD) (GERD) (GERD)

3.

Adachi A Japan
2016

UGE

191
89
(68.2%) (31.8 %)

52

4.

Deppe H Germany
2015

UGE,
pHm

30
41
49.7 ±
(42.3%) (57.7 %) 15.1

NA

257
(91.8%)

NA

23
(8.2%)

71

29

42

(100%) (40.8%) (59.1%)

66
121 AC, C,
(35.3%) (64.7%) Gi, Gl,
L, OSF,
U

X

[17]

Gi, Gl,
PE

X

[13]

P

[18]

Gl, P,
PE

[19]
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5. Yoshikawa Japan
H
2012
6.

Corrêa
MC
2012

Brazil

UGE

21
19
68.8
30
40
18
22
(52.5%) (47.5 %) (GERD) (42.9 %) (57.1%) (45 %) (55 %)
(GERD) (GERD)

UGE,
pHm,
Ma

20
40
33.41
30
(33.3%) (66.6 %) (GERD) (50 %)

7. Di Fede O Italy
2008

UGE,
pHm

89
111
46.9
100
200
(44.5%) (55.5 %) (M), (33.3 %) (66.6%)
(GERD) (GERD) 49.3 (F)

8.

UGE,
pHm

58
62
44.18
98
(48.3%) (51.6 %) (M),
(45 %)
(GERD) (GERD) 48.8 (F)

Gi, U

30
10
20
(50%) (33.3 %) (66.6 %)

PE

Italy

Corrêa
MC
2008

Brazil

UGE,
pHm,
Ma

41
(41 %)

50
(50 %)

U

10. Muñoz JV Spain
2003

UGE,
pHm

71
110
47.8 ±
72
181
(39.2%) (60.7 %) 14.1 (28.4 %) (71.6%)
(GERD) (GERD)

Gi

59
(59 %)

35.5 ±
12.9

50
(50 %)

[12]

X

[15]

OABS,

[20]

SH, X

Campisi
G
2008

9.

OABS,

SH, X

120
(55 %)

OABS,

[16]

X

OABS

[21]

[22]

UGE- upper gastrointestinal endoscopy, GF- gastrointestinal fiberscope, pHm- esophageal pH monitoring, Ma – esophageal
manometry, GERD- gastroesophageal reflux disease, M- males, F- females, SD- standard deviation, ERD- erosive esophagitis,
NERD- nonerosive reflux disease, DE- dental erosion, AC- angular cheilitis, C-Candidiasis, Gi- gingivitis, Gl- glossitis,
L- leucoplakia, OSF- oral submucous fibrosis, U- ulceration, P-periodontitis, PE- palate erythema, X- xerostomia,
OABS- oral/acid burning sensation, SH- subjective halitosis, NA- not applicable, DE- dental erosions
*Bold- studies included in the meta-analysis

Narrative synthesis. The descriptive characteristics of
the included studies are presented in Table 3. One study
was case-control [20], and 9 were cross-sectional reports.
The included studies were published between 2003 and
2019. All studies used UGE (upper gastrointestinal

endoscopy) for the confirmation of GERD. Six (60%)
studies also used pH monitoring [15,16,19–22], with
further 2 (20%) including esophageal manometry [15,21]
in the diagnosis. One study reported the use of a
gastrointestinal fiberscope [13].

Table 3. Measurement characteristics
No.

Lesion/Complaint

Measurement

1.

angular cheilitis (AC)

WHO screening protocol (Warsi 2019),

2.

candidiasis (C)

WHO screening protocol (Warsi 2019),

3.

gingivitis (Gi)

WHO screening protocol (Warsi 2019), PMA index (Watanabe 2017, Yoshikawa 2012 ),
gingival hemorrhage index 0/1/2/3 – Munoz 2003, length of gingival recessions 0/1/2 –
Munoz 2003

4.

glossitis (Gl)

WHO screening protocol (Warsi 2019), clinical examination (Watanabe 2017), clinical
examination 0/1/2 (Deppe 2015, Yoshikawa 2012 )

5.

leucoplakia (L)

WHO screening protocol (Warsi 2019),

Lesion
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6.

palate erythema (PE)

clinical examination (Watanabe 2017), clinical examination (Deppe 2015 0/1/2, Di Fede
2008)

7.

periodontitis (P)

LDH and Hb concentrations in saliva (Adachi 2016), CAL – clinical attachment loss
WHO probe (mm) (Deppe 2015)

8.

oral submucous
(OSF) fibrosis

OSF staging index (Warsi 2019),

9.

ulceration (U)

WHO screening protocol (Warsi 2019), clinical Examination (Yoshikawa 2012)

10.

oral/acid burning
sensation (OABS)

interview (Watanabe 2017, Yoshikawa 2012, Di Fede 2008, Campisi 2008, Corrêa 2008),

11.

subjective halitosis
(SH)

interview (Watanabe 2017, Yoshikawa 2012, Di Fede 2008),

12.

xerostomia (X)

WHO screening protocol (Warsi 2019), Saxon test – salivary flow volume (g/2 min)
(Watanabe 2017, Yoshikawa 2012), interview (Watanabe 2017, Yoshikawa 2012, Di Fede
2008, Campisi 2008 – standardized questions, Corrêa 2008), stimulated salivary flow
(ml/min) (Corrêa 2012, Campisi 2008)

Complaint

WHO- World Health Organization, PMA- papillary marginal attachment index, LDH- lactate dehydrogenase,
Hb- hemoglobin, OSF- oral submucous fibrosis

Table 4. Quantitative analysis comparing non-dental oral cavity lesions in GERD patients versus healthy controls
Lesion/Complaint

No. of
studies

Controls

2

OASB
Interview
(OR, 95% CI)

P value

I2

GERD
patients

Effect Size Metric

80

145

0.33 (-0.50 to 1.17)

0.43

87.6%
(p=0.005)

-

5

328

515

6.66 (2.66 to 16.67)

<0.001

65.2%
(p=0.02)

0.03

Subjective halitosis
(OR, 95% CI)

3

180

345

3.61 (1.01 to 12.92)

0.048

32.0%
(p=0.23)

0.27

Xerostomia
Saxon test
(SMD, 95% CI)

4

208

295

-0.57 (-1.06 to -0.08)

0.02

84.2%
(p<0.001)

0.89

Xerostomia
Interview
(OR, 95% CI)

2

198

320

3.29 (2.26 to 4.80)

<0.001

0.00%
(p=0.92)

-

(SMD / OR)

(P value)

Publication bias
(P value)

Lesion
Gingivitis
PMA index
(SMD, 95% CI)
Complaint

PMA- papillary marginal attachment index, GERD- gastroesophageal reflux disease, SMD- standardized mean difference,
OR- odds ratio, CI- confidence interval, OABS- oral acid burning sensation
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Lesions. The most frequently reported oral lesions were
gingivitis [12,13,17,22] and glossitis [12,13,17,19],
followed by palatal erythema [13,19,20]. Two studies
reported periodontitis [18,19] and another two oral
ulcerations [12,17]. The reported prevalence of gingivitis
in GERD patients ranged from 50.8 to 67.4% [21,22],
while glossitis was reported in 5.6-7.6% of the cases
[13,19]. One study reported a prevalence of 52.1% for
periodontitis in GERD patients [19], while 14-21.5% of
GERD patients presented palate erythema [19,20].
Complaints. The most reported prevalent complaint
was xerostomia [12,13,15–17,19,21], followed by oral acid
burning sensation [12,13,16,20,21] and subjective halitosis
[12,13,20]. The reported prevalence of xerostomia in
GERD patients ranged from 45.7 to 57.5% [12,13,16,20].
The oral acid burning sensation was present in 17.5-52%
of GERD patients [12,13,16,20,21], while subjective
halitosis was reported in 7.5-49.2% of the cases [12,13,20].
Quantitative synthesis. A total of 1,694 subjects were
included, with 687 in the control group and 1,507 patients
with GERD. A meta-analysis was performed separately for
each type of lesion/complaint and each analysis included 2
to 5 articles, depending on the reporting data (Table 4).
Gingivitis. Two studies, which reported gingivitis as
PMA index, were eligible for the meta-analysis12,13. The
cumulative analysis (SMD = 0.33, 95% CI: -0.50 to 1.17,
p = 0.43) revealed a small, non-significant difference
between patients with GERD and controls (Table 4, Figure 2).

Figure 2. Forest plot summarizing PMA index in
GERD patients versus controls
PMA- papillary marginal attachment index, GERDgastroesophageal reflux disease, CI- confidence interval

Oral acid burning sensation. Five studies, which
reported oral acid burning sensation were analyzed
quantitatively [12,13,16,20,21]. Patients with GERD had a
high cumulative OR (6.66, 95% CI: 2.66 to 16.67, p <
0.001) of experiencing acid burning sensation compared to
controls (Table 4, Figure 3).

Figure 3. Forest plot summarizing OABS in GERD patients
versus controls. OABS- oral acid burning sensation, GERDgastroesophageal reflux disease, CI- confidence interval
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Despite the large effect size, a moderate heterogeneity
(I2= 65.2%, p = 0.02) and a significant publication bias (p
= 0.03) indicate a significant difference in the evidence
(Figure 4).

Figure 4. Funnel plot summarizing publication bias of
studies which reported OABS in GERD patients
versus controls
OABSoral
acid
burning
gastroesophageal reflux disease

sensation,

GERD-

Subjective halitosis was reported and quantitatively
analyzed in three studies [12,13,20]. GERD was associated
with a moderate cumulative OR (3.61, 95% CI: 1.01 to
12.92, p = 0.048) of experiencing halitosis compared to
controls (Table 4, Figure 5).

Figure 5. Forest plot summarizing reported subjective
halitosis in GERD patients versus controls
GERD- gastroesophageal reflux disease, CI- confidence
interval

The results were robust with low heterogeneity (I2=
32%, p = 0.23) and acceptable publication bias (p = 0.27)
(Figure 6).

Figure 6. Funnel plot summarizing publication bias of
studies which reported subjective halitosis in GERD
patients versus controls
GERD- gastroesophageal reflux disease

Non-dental oral lesions in gastroesophageal reflux

Xerostomia was reported by assessing the stimulated
salivary function in four studies [12,13,15,16] and by
interview, reporting the OR in two studies [16,20]. The
SMD for the studies reporting the Saxon test score was
moderately decreased in patients with GERD (SMD = 0.57, 95% CI: -1.06 to -0.08, p = 0.02) compared to
controls (Table 4, Figure 7).

Figure 7. Forest plot summarizing the Saxon test in GERD
patients versus controls
GERD- gastroesophageal reflux disease, CI- confidence
interval

The studies showed significant heterogeneity (I2
=84.2%, p < 0.001) and acceptable publication bias (p =
0.89) (Figure 8).

Figure 8. Funnel plot summarizing publication bias of
studies which reported the Saxon test in GERD patients
versus controls
GERD- gastroesophageal reflux disease

Meanwhile, the analysis of the two studies reporting
OR showed a moderately increased risk (OR = 3.29, 95%
CI: 2.26 to 4.80, p < 0.001) in patients with GERD versus
controls, with low heterogeneity (p = 0.92) (Table 4, Figure
9).

Figure 9. Forest plot summarizing reported xerostomia in
GERD patients versus controls
OABSoral
acid
burning
sensation,
GERDgastroesophageal reflux disease, CI- confidence interval

This systematic review with meta-analysis indicates
that individuals diagnosed with GERD are at an increased
risk of presenting oral acid burning sensation, subjective
halitosis or xerostomia compared to controls without
GERD. Non-dental oral cavity lesions such as angular
cheilitis, candidiasis, gingivitis, glossitis, leucoplakia,
palate erythema, periodontitis, oral submucous fibrosis and
ulceration may stand as extraesophageal manifestations of
GERD. This review highlights the novel fact that nondental oral cavity lesions are more frequent in patients
diagnosed with GERD than in non-GERD controls. The
risk of developing oral lesions such as dental erosions in
these patients has been repeatedly investigated and
numerous data supporting this association are available
[23–27], but the association with non-dental oral cavity
lesions/complaints is still insufficiently investigated and
controversial.
The biologically possible explanation for the presence
of non-dental oral cavity lesions in patients with GERD
could stand in the repeated exposure to gastric acid or
acidic vapors over a prolonged period of time [25]. Patients
with GERD present a reduced tone of the lower esophageal
sphincter, which potentates the backflow of the gastric
content up to the mouth and airways [28]. Esophagitis
stands as the most common complication of GERD, the
condition being diagnosed and staged by means of upper
digestive endoscopy [3]. Other complications are
represented by Barret’s esophagus and adenocarcinoma
[29]. Currently, an endoscopic examination is not routinely
recommended for patients with oral lesions such as dental
erosions due to its high cost and patient discomfort [30].
To our knowledge, a standardized oral examination has not
yet been defined for GERD patients. Moreover, injured
oral mucosa negatively impacts the quality of life,
especially functional limitation, physical inability and
psychological disabilities and could lead to social isolation
[31].
The strengths of this systematic review are represented
by the rigorous methodology that was applied for the study
selection and data extraction following the PRISMA
guidelines. A meta-analysis was conducted for the
occurrence of gingivitis diagnosed by means of the PMA
index, oral acid burning sensation, subjective halitosis and
xerostomia, estimating the odds of developing these
conditions in GERD patients. In all 10 included studies, the
oral cavity assessment was performed by trained dentists
and
GERD
was
diagnosed
by
experienced
gastroenterologists.
The limitations of the study include an important
heterogeneity of methods for reporting non-dental oral
cavity lesions and complaints, which prevented the
quantitative analysis of some studies. Due to the small
number of studies which met the inclusion criteria, those
reporting ongoing IPP were not excluded. In some cases,
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subgroups were merged to form a single group to enable
the comparative analysis. In some cases, the calculation of
the publication bias was not possible. The majority of the
studies included in the meta-analysis had high levels of
heterogeneity, suggesting that the results should be
interpreted with caution. Even though some studies
reported data for NERD versus ERD patients, it could not
be used to generate conclusive results. The studies included
in the review had a cross-sectional or case report design
which could not present the temporal association between
GERD and non-dental oral cavity lesions. Finally, this
review was limited to English publications, therefore it is
possible to have missed relevant publications on the topic.
This study highlights the need for the dental referral of
patients diagnosed with GERD. We suggest that a
standardized dental clinical examination should be
included in the management of these patients. The results
of this study indicate the importance of identifying nondental oral cavity lesions and complaints in the diagnosis
of GERD and possibly including a new subtype of GERD
associated with oral non-dental manifestations in the
Montreal consensus recommendations [32].

Highlights
✓ Patients with GERD are at risk of developing oral acid
burning sensation, subjective halitosis and xerostomia.
✓ Non-dental oral cavity lesions such as angular
cheilitis, candidiasis, gingivitis, glossitis, leucoplakia,
palate erythema, periodontitis, oral submucous
fibrosis
and
ulceration
could
represent
extraesophageal manifestations of GERD.

Conclusions
The results of this systematic review with metaanalysis indicate that patients with GERD are at high risk
of developing oral acid burning sensation, subjective
halitosis and xerostomia compared to non-GERD controls.
Non-dental oral cavity lesions such as angular cheilitis,
candidiasis, gingivitis, glossitis, leucoplakia, palate
erythema, periodontitis, oral submucous fibrosis and
ulceration could represent extraesophageal manifestations
of GERD.
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